Infl ammatory pseudotumor is a well known but poorly understood pathologic entity. It is associated with an unusual growth of fi brotic tissue admixed with varying amounts of infl ammation that displaces and compresses normal anatomic structures, resulting in dysfunction. Pseudotumors have been found in multiple locations-the orbit in particular-but to the best of our knowledge, none has previously been reported as an isolated sinus lesion. We describe a case of primary sclerosing fi broinfl ammatory pseudotumor of the maxillary sinus that manifested as recurrent unilateral maxillary sinusitis in a 47-yearold woman. Th e patient was managed with surgery and oral steroids with full resolution of her symptoms. We also review the presentation, diagnosis, and treatment of fi broinfl ammatory pseudotumors within the context of the current literature.
Introduction
Fibrosclerosing disorders have been associated with many parts of the body, including the head and neck, thorax, and abdomen. Pseudotumors of the head and neck have historically and classically manifested as an infl ammatory disease of the orbit, which represents the most well-characterized presentation in the literature. Histopathologically, these tumors produce a broad spectrum of fi ndings, ranging from predominantly lymphoid tissue to highly fi brotic tissue. 1, 2 In rare cases, orbital pseudotumors have been associated with other fi broinfl ammatory diseases, such as retroperitoneal fi brosis, sclerosing cholangitis, Riedel thyroiditis, mediastinal fi brosis, and fi brosis of the lung, parotid gland, and lacrimal glands. 1 In this article, we present what we believe is the fi rst reported case of an isolated fi brosclerotic pseudotumor of a sinus, which was seen in a patient with chronic rhinosinusitis.
Case report
A 47-year-old white woman with recurrent left maxillary sinusitis refractory to medical management (e.g, amoxicillin/clavulanate, prednisone, and fl uticasone nasal spray) underwent a middle meatal antrostomy; histopathology was reported as nonspecifi c fi brosis. At about the same time, she underwent fi ne-needle aspiration of a left neck lymph node at another institution; the cytology identifi ed nonspecifi c infl ammatory changes and parotid tissue. Two months later, she presented to us with left cheek and periorbital pain that radiated to the ear, along with left nasal congestion, rhinorrhea, and sneezing.
Fiberoptic examination of the nose revealed wellhealed fi brotic maxillary and ethmoid sinuses. Computed tomography (CT) demonstrated left maxillary opacifi cation and expansion (fi gure 1). Th e sinus was fi lled with hyperdense material with central hypodensity, and the walls were thickened. Th e left lamina papyracea was thinned medially, with bowing of material into the inferior orbit. However, orbital fat planes were maintained, and there was no frank invasion of the orbit. Th ese fi ndings suggested isolated maxillary sinus involvement.
Th e patient underwent an endoscopic left modifi ed that later evolves into dense collagen formation and fi brosis. According to this theory, nonsclerosing infl ammatory conditions are subclassifi ed into three subtypes: lymphoid, fi brotic, and mixed. Th e sclerosing variant of pseudotumor is pathologically distinct, given its aggressive, locally destructive course that results in bone loss. Unlike the nonsclerosing type, the sclerosing form cannot be grouped into one of the three categories, despite the seemingly similar origins of the two types. Several authors have noted that sclerosing disease processes, including sclerosing orbital pseudotumor, are oft en associated with multifocal sclerotic disease processes. 1, 3, 5 Retroperitoneal fi brosis, sclerosing cholangitis, Riedel thyroiditis, and sclerosing mediastinitis are all associated with orbital pseudotumors, and they provide a basis for a unifying autoimmune or genetic cause. 1, 3, 5 Our patient presented with fi ne-needle aspiration cytology results obtained at another institution at about the same time that she was diagnosed at our institution; these cytologic fi ndings were consistent with infl ammatory changes of the parotid gland, which were suggestive of a more diff use infl ammatory process.
Pseudotumors of the orbit oft en present unilaterally in adults; there is no predilection for either sex or any race. 1, 2, 5, 6 Th e clinical presentation usually includes progressive proptosis, pain, limitation of extraocular medial maxillectomy and left frontal sinusotomy. Intraoperatively, a granular and friable mass was seen fi lling the maxillary sinus. Th e mass was elevated away from the bone and removed circumferentially from the walls of the sinus. Frozen-section analysis during surgery confi rmed the presence of a fi brotic process, and the fi nal histopathologic examination confi rmed the diagnosis of sclerosing fi broinfl ammatory pseudotumor (fi gure 2A). Th e patient's postoperative course was uncomplicated, and she was discharged home the same day.
Immunohistochemistry was positive for smoothmuscle actin (fi gure 2B), and negative for S-100, keratin, CD34, epithelial membrane antigen, progesterone receptor, and desmin. She was prescribed methylprednisolone.
At the 6-month follow-up, the patient was doing well. Magnetic resonance imaging at that time demonstrated evidence of a soft -tissue mass in the area of the left maxillary sinus without orbital involvement or bony invasion. Th is mass was believed to represent either residual pseudotumor or thickened mucosa. Endoscopic examination at approximately the same time revealed that her left maxillary sinus had contracted completely; there was evidence of osteoneogenesis but no evidence of recurrence. At 21 months of follow-up, the patient remained free of recurrence.
Discussion
Infl ammatory pseudotumor is a generic term used to describe a mass that displaces the surrounding anatomic structures and leads to organ dysfunction secondary to compressive growth. Fibroinfl ammatory disorders include heterogeneous clinical entities whose etiologies and pathogenesis remain unknown. [1] [2] [3] Th ey can be subdivided into two types: sclerotic and nonsclerotic. Th e sclerotic type is locally more aggressive and less responsive to therapy. To the best of our knowledge, no case of isolated fi brosclerosing pseudotumor of a sinus has been previously reported in the literature.
Much of what is known about pseudotumors has been gleaned from the ophthalmology literatureparticularly, from discussions of the more common orbital pseudotumor. Th is knowledge provides a foundation for understanding the presentation, diagnosis, and management of a sclerosing pseudotumor of the maxillary sinus.
Th e etiology of the sclerosing variant of fi broinfl ammatory disorders remains unclear. Some authors, including Jakobiec and Jones, 4 have noted that the nonsclerosing disease process begins with lymphocytic involvement Continued on page 590 movement, diplopia, and vision loss over a period of months. 1, 2, 5, 6 Orbital pseudotumor may also be associated with increases in the erythrocyte sedimentation rate, white blood cell count, gamma globulin levels, and eosinophil level, as well as rheumatoid factor positivity and an elevated antinuclear antibody level.
In our case, the patient's white blood cell count was within normal limits. Her autoimmunity workup was pursued by her primary care physician, and at our last follow-up, she was autoimmunologically negative. Our patient had presented in typical fashion, with compressive and obstructive symptoms of the maxillary sinus that resulted in pain, congestion, and rhinorrhea. However, we found no evidence of frank orbital invasion or compression of the infraorbital nerve.
Pseudotumors can be treated either medically or surgically. Th e mainstay of medical therapy is an oral or intravenous steroid, with or without radiation therapy. [1] [2] [3] 5, 6 Th e nonsclerosing subtypes of orbital infl ammation respond to steroids rapidly and dramatically, whereas the sclerosing variant that develops as a chronic, slowly progressive disease responds poorly. 2, 5, 6 Our patient was initially treated with a course of oral prednisone and nasal steroids without experiencing any symptomatic relief. Aft er we debulked her mass endoscopically, we noted an improvement in her clinical response to steroid administration. Some evidence suggests that the sclerosing variant is more likely to respond to oral steroids if the duration of the disease course has been brief. 2 Brannan advocated the use of high-dose (2 mg/kg) oral prednisolone or intravenous methylprednisolone as initial therapy followed by radiotherapy and/or surgical debulking. 2 Adjunctive treatments with chemotherapeutic drugs (e.g., cyclophosphamide) and immune system modulators (e.g., rituximab and azathioprine) used in a limited fashion have been successful, and these regimens are emerging as possible treatment alternatives to steroid therapy. 2, 6 However, because of the limited prevalence of the sclerosing variant, there is no specifi c guideline for its treatment.
Surgical excision or debulking of sclerotic lesions is another viable treatment alternative. 2,5 Mombaerts et al described a cohort of 23 patients who experienced complete cure following either total surgical excision (n = 9) or debulking (n = 14) of orbital pseudotumors, with or without adjunctive corticosteroid or radiation therapy. 5 Seven of these patients were successfully treated with surgery alone, and another 4 were successfully treated with surgery alone aft er a steroid trial had failed.
Our patient had residual fi brotic lesions refractory to steroid treatment, but she responded well to surgical excision with adjunctive steroid therapy. However, the need for complete excision remains uncertain. Jakobiec and Jones 4 and Jakobiec and Font 7 have noted that incomplete surgical excision may result in a worsening of symptoms caused by a reactivation of the immune system. However, that contention has been disputed by Brannan 2 and Mombaerts et al, 5 who have noted that a partial excision may provide signifi cant symptomatic relief secondary to an infl ammatory "burnout" phenomenon. Unfortunately, there is no standard of care at this time, and treatment is left to the discretion of the practitioner in each situation.
Regardless of treatment, the prognosis for patients with sclerosing infl ammatory lesions is favorable, as most for further investigations into trismus rehabilitation with the DTS. Comparisons of the DTS device with the Th eraBite device and with tongue blades have not been statistically assessed. Given the impressive early response to the DTS in our study, a trial of DTS therapy followed by a less expensive maintenance therapy may provide an ideal regimen.
experience a complete resolution of symptoms. Our own experience was consistent with this fi nding. Practicing otolaryngologists must be cognizant of this disease process and its appropriate treatment possibilities. Furthermore, it is imperative that practitioners consider systemic infl ammatory diseases when a patient presents with an isolated infl ammatory pseudotumor, which may be a harbinger of more widespread disease.
In conclusion, as this case shows, sclerosing infl ammatory pseudotumor can be localized to the maxillary sinus without orbital involvement. Th e traditional treatment of oral steroids for nonsclerosing pseudotumors may not be eff ective for patients with the fi brosclerotic variant. Surgical excision is a viable treatment alternative. Clinicians should be aware of the rare presentation of fi brosclerotic pseudotumor when exploring a mass lesion of an infl ammatory nature in the maxillary sinus.
